Neostigmine is preferred to physostigmine in the treatment of myasthenia gravis because: (a) It has additional direct stimulating effect on nicotinic receptors at the muscle end plate (b) It has longer duration of action (c) It is better absorbed orally (d) It does not penetrate blood brain barrier
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.